Entheon Biomedical: Could DMT Be A Superior Psychedelic Treatment For Substance Use Disorder? Feb 4, 2022
Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT Aug 27, 2021
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated… Aug 16, 2021
PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT… Aug 5, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
